HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Souad Elkhattabi Selected Research

dimedone

7/2021QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Souad Elkhattabi Research Topics

Disease

1COVID-19
01/2022
1Neoplasms (Cancer)
07/2021

Drug/Important Bio-Agent (IBA)

1EnzymesIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Proto-Oncogene Proteins c-metIBA
07/2021
1CrizotinibIBA
07/2021
1dimedoneIBA
07/2021

Therapy/Procedure

1Therapeutics
01/2022